Trinity Innovation Fund
Overview
Trinity Innovation Fund is a venture capital firm that makes early and growth-stage investments in the biotechnology, drug discovery, and pharmaceutical industries.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Adcentrx Therapeutics | Apr 2023 | Series A Extension | Co-investor |
| VelaVigo | Nov 2021 | Angel | Co-investor |
| Epigenic Therapeutics | Aug 2022 | Seed | Co-investor |
| Zhimeng Biopharma | Nov 2020 | Series A | Lead |
| Bluepha | Jan 2022 | Series B | Co-investor |
For institutional investors. Book with your work email.
Key People
Adam Wang
Investment Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Trinity Innovation Fund based?
Trinity Innovation Fund is headquartered in Beijing, Central Singapore, China.
When was Trinity Innovation Fund founded?
Trinity Innovation Fund was founded in 2018.
How many portfolio companies does Trinity Innovation Fund have?
Trinity Innovation Fund has 11 portfolio companies in Caplight's dataset.
What are some companies in Trinity Innovation Fund's portfolio?
Portfolio companies visible on Caplight include Adcentrx Therapeutics, VelaVigo, Epigenic Therapeutics, Zhimeng Biopharma, Bluepha.
What was Trinity Innovation Fund's most recent investment shown here?
Trinity Innovation Fund's most recent investment in this portfolio sample was in Adcentrx Therapeutics in 2023.
What sectors does Trinity Innovation Fund focus on?
Trinity Innovation Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability.
What company stages does Trinity Innovation Fund focus on?
Trinity Innovation Fund typically invests at the Early stage.